MCRB Seres Therapeutics, Inc. - Common Stock
$4,59
Prezzo · Ago 19, 2026
Fondamentali al Ago 5, 2026
Intervallo 52 sett.
$4–$30
1% of range
Rating Analisti
BUY
8 analysts
Prezzo Obiettivo
$17
+270% upside
P/E (TTM)
7.2
ROE
14.8%
Margine di Profitto Netto
721.9%
MCRB Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$4.59
Capitalizzazione di Mercato
$44M
P/E (TTM)
7.2
EPS (TTM)
$0.64
Ricavi (TTM)
$789.0K
Rendimento div.
—
ROE
14.8%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$4 – $30
MCRB Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$789.0K
2016-12-31
→
2025-12-31
EPS
$0.64
2020-12-31
→
2025-12-31
Flusso di cassa libero
$865.0K
2016-12-31
→
2025-12-31
Margini
721.9%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
MCRB
Mediana dei peer
P/E (TTM)
7.2
0.8
P/S (TTM)
55.8
6.2
P/B
1.0
3.0
Price / FCF (Prezzo / FCF)
50.9
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
MCRB
Mediana dei peer
Operating Margin (Margine Operativo)
-11910.1%
—
Net Profit Margin (Margine di Profitto Netto)
721.9%
-1056.6%
ROA
4.1%
-118.6%
ROE
14.8%
-139.5%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
MCRB
Mediana dei peer
Current Ratio (Rapporto corrente)
2.6
2.1
Quick Ratio
2.4
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
MCRB
Mediana dei peer
Revenue CAGR 3Y (CAGR Ricavi 3Y)
-52.0%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
-52.7%
—
Net Income YoY (Utile Netto YoY)
4088.2%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
MCRB
Mediana dei peer
MCRB Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
8 analisti
- Acquisto forte 2 25,0%
- Compra 5 62,5%
- Mantieni 1 12,5%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
2 analisti · 2026-08-15
Mediana
$17.00
← Sotto tutti i target
$4.59
Basso
$12.00
Alto
$22.00
Target mediano
$17.00
+270,4%
Target medio
$17.00
+270,4%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.26%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-1.50 | $-2.23 | 0.73% |
| 31 Marzo 2026 | $-2.08 | $-1.92 | -0.16% |
| 31 Dicembre 2025 | $-1.78 | $-2.15 | 0.37% |
| 30 Settembre 2025 | $0.94 | $1.31 | -0.37% |
| 30 Giugno 2025 | $-2.27 | $-2.54 | 0.27% |
| 31 Marzo 2025 | $-2.96 | $-0.55 | -2.4% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| MCRB | $142M | 23.2 | — | 721.9% | 14.8% | — |
| MGX | $61M | -0.7 | -51.8% | -348.5% | -49.6% | — |
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | — |
| TVGN | — | — | — | — | — | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| ALGS | $58M | -3.8 | -39.5% | -1106.7% | -31.1% | — |
| CRVO | $73M | — | -58.9% | -673.1% | -104.4% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $789.0K | $0 | $0 | $7M | $145M | $33M | $35M | $28M | $32M | $22M | $0 | |
| R&D Expense | $49M | $65M | $118M | $110M | $142M | $91M | $80M | $96M | $89M | $82M | $38M | |
| SG&A Expense | $39M | $53M | $78M | $70M | $69M | $31M | $25M | $33M | $34M | $33M | $17M | |
| Operating Expenses | $95M | $121M | $195M | $180M | $209M | $121M | $106M | $129M | $123M | $115M | $55M | |
| Operating Income | $-94M | $-121M | $-195M | $-180M | $-64M | $-88M | $-72M | $-100M | $-91M | $-93M | $-55M | |
| Interest Income | $2M | $4M | $7M | $3M | $3M | $946.0K | $1M | $1M | $2M | · | · | |
| Other Non-op | $17M | $-14M | $134.0K | $-705.0K | $-1M | $981.0K | $1M | $1M | $2M | $1M | $76.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $6M | $136.0K | $-114M | $-250M | $-66M | $-89M | $-70M | $-99M | $-89M | $-92M | $-55M | |
| EPS (Basic) | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 | $-1.12 | · | · | · | · | · | |
| EPS (Diluted) | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 | $-1.12 | · | · | · | · | · | |
| Shares (Basic) | 8,858,975 | 7,769,910 | 6,400,339 | 108,077,043 | 91,702,866 | 79,789,220 | · | · | · | · | · | |
| Shares (Diluted) | 8,869,742 | 7,769,910 | 6,400,339 | 108,077,043 | 91,702,866 | 79,789,220 | · | · | · | · | · | |
| EBITDA | $-90M | $-116M | $-102M | $-240M | $-59M | $-82M | $-64M | $-92M | $-84M | $-89M | $-54M |
Stato Patrimoniale 25
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $31M | $128M | $163M | $180M | $116M | $65M | $86M | $36M | $55M | $74M | |
| Short-term Investments | · | · | $0 | $18M | $111M | $138M | $30M | · | $114M | $139M | $131M | |
| Receivables | $157.0K | $0 | · | · | · | $9M | $2M | · | · | · | · | |
| Inventory | · | · | $30M | $0 | · | · | · | · | · | · | · | |
| Prepaid Expense | $3M | $6M | $8M | $13M | $13M | $6M | $4M | $7M | $5M | $5M | $3M | |
| Current Assets | $49M | $39M | $175M | $195M | $304M | $269M | $100M | $93M | $155M | $198M | $208M | |
| PP&E (Net) | $8M | $12M | $18M | $23M | $18M | $14M | $19M | $26M | $33M | $36M | $8M | |
| PP&E (Gross) | $64M | $65M | $67M | $68M | $58M | $48M | $47M | $47M | $45M | $41M | $9M | |
| Accum. Depreciation | $57M | $53M | $49M | $45M | $40M | $34M | $28M | $20M | $12M | $5M | $1M | |
| Other Non-current Assets | $31.0K | $31.0K | $2M | $10M | $5M | · | · | · | · | · | · | |
| Total Assets | $138M | $140M | $359M | $349M | $355M | $343M | $132M | $120M | $190M | $273M | $217M | |
| Accounts Payable | $2M | $4M | $4M | $17M | $14M | $4M | $5M | $6M | $7M | $8M | $5M | |
| Short-term Debt | · | · | $0 | $456.0K | $0 | $454.0K | · | · | · | · | · | |
| Current Liabilities | $19M | $41M | $99M | $86M | $82M | $46M | $46M | $42M | $32M | $30M | $11M | |
| Capital Leases | $73M | $83M | $92M | $108M | $18M | $11M | $16M | · | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $1M | $11M | $1M | $502.0K | $644.0K | $1M | · | · | |
| Total Liabilities | $94M | $126M | $403M | $338M | $223M | $168M | $181M | $169M | $129M | $140M | $12M | |
| Long-term Debt | · | · | $110M | $50M | $24M | $25M | $25M | · | · | · | · | |
| Total Debt | · | · | $0 | $456.0K | · | $454.0K | · | · | · | · | · | |
| Common Stock | $10.0K | $9.0K | $135.0K | $125.0K | $92.0K | $91.0K | $70.0K | $41.0K | $40.0K | $40.0K | $39.0K | |
| Retained Earnings | $-972M | $-978M | $-978M | $-865M | $-614M | $-549M | $-460M | $-389M | $-264M | $-174M | $-83M | |
| AOCI | · | $0 | $0 | $-12.0K | $-60.0K | $-47.0K | · | · | $-146.0K | $-149.0K | $30.0K | |
| Stockholders' Equity | $44M | $14M | $-45M | $11M | $132M | $175M | $-48M | $-48M | $61M | $133M | $205M | |
| Liabilities + Equity | $138M | $140M | $359M | $349M | $355M | $343M | $132M | $120M | $190M | $273M | $217M | |
| Shares Outstanding | 9,556,466 | 8,650,227 | 6,752,073 | 6,261,400 | 91,889,418 | 91,459,239 | 70,143,252 | 40,936,735 | 40,571,015 | 40,355,753 | 39,082,017 |
Flusso di cassa 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $5M | $6M | $7M | $6M | $7M | $8M | $8M | $7M | $4M | $728.0K | |
| Stock-based Comp | $11M | $21M | $34M | $25M | $20M | $9M | $8M | $17M | $17M | $17M | $10M | |
| Restructuring | $1M | · | $6M | · | $0 | $0 | $1M | $0 | $0 | · | · | |
| Other Non-cash | $-20M | $-175M | $-44M | $-11M | $46M | $-20M | $-22M | $12M | $-11M | $114M | $4M | |
| Operating Cash Flow | $1M | $-149M | $-117M | $-229M | $7M | $-94M | $-77M | $-63M | $-76M | $44M | $-41M | |
| CapEx | $252.0K | $380.0K | $8M | $10M | $10M | $591.0K | $1M | $2M | $5M | $21M | $4M | |
| Investing Cash Flow | $-42.0K | $142M | $11M | $82M | $64M | $-159M | $-31M | $112M | $56M | $-66M | · | |
| Debt Issued | · | · | · | $28M | $0 | $0 | $25M | · | · | · | · | |
| Net Debt Issued | · | · | · | $28M | · | · | $25M | · | · | · | · | |
| Stock Issued | · | $0 | $0 | $97M | $0 | $244M | $61M | · | · | · | $143M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $33.0K | · | · | |
| Net Stock Activity | · | $0 | $0 | $97M | · | $244M | $61M | · | $-33.0K | · | $143M | |
| Financing Cash Flow | $14M | $-90M | $72M | $130M | $1M | $303M | $86M | $268.0K | $83.0K | $2M | · | |
| Net Change in Cash | · | · | · | · | · | $51M | $-21M | $50M | $-20M | $-20M | $-40M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $865.0K | $-149M | $-125M | $-239M | $-3M | $-94M | $-78M | $-65M | $-80M | $22M | $-45M |
Redditività 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -11910.1% | · | -85.5% | -3458.1% | -44.5% | -265.3% | -208.3% | -354.8% | -284.7% | -426.5% | · | |
| Net Margin | 721.9% | · | -90.0% | -3509.5% | -45.2% | -268.3% | -203.7% | -350.0% | -278.4% | -420.7% | · | |
| EBITDA Margin | -11386.3% | · | -80.5% | -3365.1% | -40.4% | -245.5% | -186.3% | -327.0% | -262.1% | -407.2% | · | |
| ROA | 4.1% | 0.05% | -32.1% | -71.1% | -18.8% | -37.5% | -55.6% | -63.8% | -38.7% | -37.4% | -32.8% | |
| ROE | 14.8% | 0.72% | 379.2% | -638.4% | -42.7% | -49.1% | 174.5% | 251.7% | -92.5% | -54.2% | -61.3% |
Liquidità e Solvibilità 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 0.9 | 1.8 | 2.3 | 3.7 | 5.8 | 2.2 | 2.2 | 4.9 | 6.5 | 19.0 | |
| Quick Ratio | 2.4 | 0.7 | 1.3 | 2.1 | 3.5 | 5.7 | 1.5 | 2.0 | 4.7 | 6.3 | 18.8 | |
| Debt / Equity | · | · | 0.0 | 0.0 | · | 0.0 | · | · | · | · | · |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.4 | 0.0 | 0.4 | 0.1 | 0.3 | 0.2 | 0.1 | 0.1 | 0.0 | |
| Receivables Turnover | 10.1 | · | · | · | · | 5.9 | 38.7 | · | · | · | · |
Tassi di Crescita 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -95.1% | 336.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -52.0% | · | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -52.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 4088.2% | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $789.0K | $0 | $0 | $7M | $145M | $33M | $35M | $28M | $32M | $22M | $0 | |
| Net Income TTM | $6M | $136.0K | $-114M | $-250M | $-66M | $-89M | $-70M | $-99M | $-89M | $-92M | $-55M | |
| Market Cap | $142M | $2.88B | $3.78B | $14.02B | $15.31B | $44.82B | $4.84B | $3.70B | $8.23B | $7.99B | $27.43B | |
| Enterprise Value | · | · | $3.65B | $13.84B | · | $44.56B | · | · | · | · | · | |
| P/E | 23.2 | · | -1.6 | -48.5 | -231.4 | -437.5 | · | · | · | · | · | |
| P/S | 180.2 | · | · | 1967.6 | 105.6 | 1349.2 | 140.3 | 130.9 | 256.3 | 367.1 | · | |
| P/B | 3.2 | 208.6 | -84.3 | 1300.6 | 116.4 | 256.5 | -100.2 | -77.0 | 135.6 | 60.2 | 133.5 | |
| P / Tangible Book | 3.2 | 208.6 | · | 1300.6 | 116.4 | 256.5 | · | · | · | · | · | |
| P / Cash Flow | 127.3 | -19.3 | -32.2 | -61.3 | 2289.0 | -478.7 | -63.2 | -58.9 | -108.9 | 181.9 | -671.5 | |
| P / FCF | 164.4 | -19.3 | -30.2 | -58.8 | -5319.2 | -475.7 | -62.4 | -57.1 | -102.6 | 356.3 | -606.7 | |
| EV / EBITDA | · | · | -35.9 | -57.7 | · | -546.4 | · | · | · | · | · | |
| EV / FCF | · | · | -29.1 | -58.0 | · | -473.1 | · | · | · | · | · | |
| EV / Revenue | · | · | · | 1942.2 | · | 1341.6 | · | · | · | · | · | |
| Earnings Yield | 4.3% | 0.00% | -63.5% | -2.1% | -0.43% | -0.23% | · | · | · | · | · |
Conto Economico 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $736.0K | $358.0K | $438.0K | $351.0K | $0 | $0 | $0 | $0 | $0 | $0 | $-126M | $310.0K | $126M | $-522.0K | · | $3M | |
| R&D Expense | $9M | $13M | $12M | $13M | $13M | $12M | $13M | $16M | $16M | $19M | $2M | $25M | $47M | $44M | $-17M | $43M | |
| SG&A Expense | $7M | $8M | $8M | $9M | $10M | $12M | $12M | $13M | $13M | $15M | $8M | $19M | $28M | $22M | $13M | $18M | |
| Operating Expenses | $22M | $21M | $20M | $23M | $25M | $27M | $29M | $29M | $29M | $34M | $4M | $45M | $77M | $70M | $-4M | $63M | |
| Operating Income | $-21M | $-21M | $-19M | $-22M | $-25M | $-27M | $-29M | $-29M | $-29M | $-34M | $-129M | $-45M | $50M | $-71M | $-2M | $-59M | |
| Interest Income | $181.0K | $325.0K | $445.0K | $618.0K | $546.0K | $618.0K | $437.0K | $652.0K | $1M | $2M | $2M | $3M | $2M | $1M | $1M | $865.0K | |
| Other Non-op | $673.0K | $669.0K | $2M | $3M | $4M | $7M | $6M | $-23M | $1M | $505.0K | $336.0K | $999.0K | $-2M | $310.0K | $-23.0K | $-33.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $5M | $-20M | $-15M | $8M | $-20M | $33M | $-16M | $89M | $-33M | $-40M | $-41M | $-48M | $47M | $-71M | $-69M | $-60M | |
| EPS (Basic) | $0.47 | $-2.08 | $-1.79 | $0.94 | $-2.27 | $3.76 | $-1.80 | $11.63 | $-4.34 | $-5.49 | $-17.19 | $-0.37 | $0.36 | $-0.57 | $-0.51 | $-0.49 | |
| EPS (Diluted) | $0.47 | $-2.08 | $-1.78 | $0.94 | $-2.27 | $3.75 | $-1.80 | $11.63 | $-4.34 | $-5.49 | $-17.19 | $-0.37 | $0.36 | $-0.57 | $-0.51 | $-0.49 | |
| Shares (Basic) | 9,706,193 | 9,582,533 | -17,346,671 | 8,758,692 | 8,743,733 | 8,703,221 | -14,742,978 | 7,632,242 | 7,575,620 | 7,305,026 | -375,465,993 | 128,289,871 | 127,713,486 | 125,862,975 | -198,870,067 | 122,527,275 | |
| Shares (Diluted) | 9,747,138 | 9,582,533 | -17,360,211 | 8,771,519 | 8,743,733 | 8,714,701 | -14,742,978 | 7,632,242 | 7,575,620 | 7,305,026 | -377,597,438 | 128,289,871 | 129,844,931 | 125,862,975 | -198,870,067 | 122,527,275 | |
| EBITDA | $-21M | $-20M | · | $-21M | $-24M | $-26M | · | $-28M | $-30M | $-38M | · | $-46M | $51M | $-69M | · | $-57M |
Stato Patrimoniale 25
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $30M | $46M | $48M | $45M | $59M | $31M | $67M | $71M | $111M | · | $170M | $230M | $95M | · | $205M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $12M | · | $28M | |
| Receivables | $274.0K | $233.0K | $157.0K | $351.0K | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | $53M | $42M | · | $19M | $5M | · | · | · | |
| Prepaid Expense | $1M | $2M | $3M | $3M | $2M | $4M | $6M | $6M | $6M | $5M | · | $9M | $9M | $10M | · | $15M | |
| Current Assets | $42M | $32M | $49M | $52M | $49M | $66M | $39M | $73M | $149M | $165M | · | $214M | $251M | $116M | · | $248M | |
| PP&E (Net) | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $13M | $18M | $19M | · | $24M | $24M | $24M | · | $19M | |
| PP&E (Gross) | $61M | $64M | $64M | $65M | $65M | $65M | $65M | $65M | $72M | $72M | · | $73M | $72M | $71M | · | $65M | |
| Accum. Depreciation | $55M | $57M | $57M | $56M | $55M | $54M | $53M | $52M | $54M | $52M | · | $50M | $48M | $46M | · | $45M | |
| Other Non-current Assets | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $465.0K | $42M | $41M | · | $12M | $11M | $11M | · | $12M | |
| Total Assets | $102M | $118M | $138M | $143M | $144M | $164M | $140M | $179M | $322M | $341M | · | $368M | $406M | $270M | · | $312M | |
| Accounts Payable | $1M | $2M | $2M | $2M | $2M | $2M | $4M | $8M | $5M | $5M | · | $9M | $13M | $12M | · | $10M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| Current Liabilities | $20M | $19M | $19M | $22M | $31M | $31M | $41M | $65M | $108M | $98M | · | $79M | $78M | $64M | · | $82M | |
| Capital Leases | $45M | $70M | $73M | $75M | $78M | $80M | $83M | $85M | $101M | $103M | · | $105M | $107M | $107M | · | $18M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $961.0K | |
| Total Liabilities | $67M | $91M | $94M | $100M | $111M | $114M | $126M | $155M | $409M | $401M | · | $383M | $384M | $318M | · | $244M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $110M | $110M | · | $110M | $110M | $50M | · | $50M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| Common Stock | $10.0K | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $170.0K | $152.0K | $151.0K | · | $129.0K | $128.0K | $127.0K | · | $124.0K | |
| Retained Earnings | $-988M | $-992M | $-972M | $-957M | $-965M | $-945M | $-978M | $-962M | $-1.05B | $-1.02B | · | $-937M | $-889M | $-936M | · | $-796M | |
| AOCI | · | · | · | $0 | $0 | · | · | $0 | $0 | $0 | · | $0 | $-1.0K | $2.0K | · | $-118.0K | |
| Stockholders' Equity | $35M | $26M | $44M | $44M | $33M | $50M | $14M | $24M | $-87M | $-60M | $-45M | $-15M | $23M | $-48M | $11M | $68M | |
| Liabilities + Equity | $102M | $118M | $138M | $143M | $144M | $164M | $140M | $179M | $322M | $341M | · | $368M | $406M | $270M | · | $312M | |
| Shares Outstanding | 9,827,569 | 9,592,326 | 9,556,446 | 8,764,664 | 8,754,482 | 8,732,187 | 8,650,227 | 170,200,253 | 151,633,922 | 151,442,034 | 6,752,073 | 128,630,689 | 128,037,679 | 126,592,604 | 125,222,273 | 124,410,917 |
Flusso di cassa 11
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $670.0K | $781.0K | $954.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | |
| Stock-based Comp | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $5M | $6M | $6M | $5M | $9M | $13M | $7M | $7M | $6M | |
| Restructuring | $0 | $914.0K | $0 | $1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $1M | · | · | · | $-10M | · | · | · | $-3M | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $-22M | $-16M | $-15M | $2M | $-13M | $27M | $-39M | $-35M | $-40M | $-35M | $-47M | $-59M | $66M | $-77M | $-53M | $-60M | |
| CapEx | $0 | $0 | $29.0K | $8.0K | $181.0K | $34.0K | $90.0K | $129.0K | $99.0K | $62.0K | $877.0K | $2M | $1M | $4M | $3M | $1M | |
| Investing Cash Flow | $14.0K | $0 | $181.0K | $-8.0K | $-181.0K | $-34.0K | $-90.0K | $141M | $1M | $-62.0K | $-877.0K | $-2M | $11M | $3M | $6M | $40M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | |
| Financing Cash Flow | $2M | $428.0K | $13M | $61.0K | $0 | $1M | $2M | $-111M | $0 | $19M | $6M | $1M | $58M | $6M | $5M | $98M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | $135M | $-68M | · | $79M | |
| Free Cash Flow | · | $-16M | · | · | · | $27M | · | · | · | $-35M | · | · | · | $-81M | · | · |
Redditività 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2890.3% | -5839.9% | · | -6403.7% | · | · | · | · | · | · | · | -15294.5% | 39.2% | 13518.8% | · | -1716.2% | |
| Net Margin | 622.4% | -5562.3% | · | 2337.3% | · | · | · | · | · | · | · | -15436.8% | 36.8% | 13634.9% | · | -1742.2% | |
| EBITDA Margin | -2799.3% | -5621.8% | · | -6106.3% | · | · | · | · | · | · | · | -14751.3% | 40.4% | 13250.6% | · | -1665.5% | |
| ROA | 3.7% | -14.1% | · | 5.1% | -8.5% | 12.9% | · | 32.5% | -9.0% | -13.1% | · | -14.1% | 13.7% | -24.1% | · | -17.0% | |
| ROE | 13.6% | -51.7% | · | 24.3% | 73.4% | -704.9% | · | 2018.6% | 102.0% | 74.6% | · | -182.4% | 203.8% | -430.2% | · | -49.3% |
Liquidità e Solvibilità 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.6 | · | 2.3 | 1.6 | 2.1 | · | 1.1 | 1.4 | 1.7 | · | 2.7 | 3.2 | 1.8 | · | 3.0 | |
| Quick Ratio | 0.8 | 1.6 | · | 2.1 | 1.5 | 1.9 | · | 1.0 | 0.7 | 1.1 | · | 2.1 | 2.9 | 1.7 | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.4 | -0.0 | · | 0.0 | |
| Receivables Turnover | 1.0 | 0.3 | · | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | · | · | · | $310.0K | $310.0K | · | $310.0K | $127M | $126M | · | $130M | $131M | $6M | · | $133M | |
| Net Income TTM | $-27M | $1M | · | $110M | $69M | $48M | · | $-32M | $-74M | $-113M | · | $-132M | $-149M | $-253M | · | $-113M | |
| Market Cap | $78M | $85M | · | $169M | $97M | $122M | · | $3.22B | $2.20B | $2.34B | · | $6.12B | $12.27B | $14.36B | · | $15.97B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.95B | $12.04B | $14.25B | · | · | |
| P/E | -2.7 | 26.1 | · | 1.4 | 1.3 | 2.5 | · | 13.2 | -1.5 | -2.6 | · | -44.5 | -68.4 | -47.8 | · | -118.9 | |
| P/S | 53.7 | · | · | · | 313.7 | 394.4 | · | 10387.7 | 17.3 | 18.6 | · | 47.2 | 93.9 | 2549.4 | · | 120.2 | |
| P/B | 2.2 | 3.2 | · | 3.9 | 3.0 | 2.4 | · | 134.6 | -25.2 | -39.2 | · | -404.9 | 542.4 | -299.9 | · | 236.4 | |
| P / Tangible Book | 2.2 | 3.2 | · | 3.9 | 3.0 | 2.4 | · | 134.6 | · | · | · | · | 542.4 | · | · | 236.4 | |
| P / Cash Flow | · | -5.2 | · | · | · | 4.5 | · | · | · | -66.5 | · | · | · | -187.4 | · | · | |
| P / FCF | · | -5.2 | · | · | · | 4.5 | · | · | · | -66.4 | · | · | · | -178.0 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -130.2 | 235.8 | -206.0 | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -176.7 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 45.9 | 92.2 | 2530.5 | · | · | |
| Earnings Yield | -37.3% | 3.8% | · | 73.0% | 78.9% | 39.6% | · | 7.6% | -68.0% | -39.2% | · | -2.2% | -1.5% | -2.1% | · | -0.84% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $789.0K | $0 | $0 | $7M | $145M |
| Margine Operativo % | -11910.1% | — | -85.5% | -3458.1% | -44.5% |
| Utile netto | $6M | $136.0K | $-114M | $-250M | $-66M |
| EPS Diluito | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | — | — | 0.0 | 0.0 | — |
| Rapporto corrente | 2.6 | 0.9 | 1.8 | 2.3 | 3.7 |
| Quick Ratio | 2.4 | 0.7 | 1.3 | 2.1 | 3.5 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $865.0K | $-149M | $-125M | $-239M | $-3M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 43 filer · $15.5M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 13 (+10 vs trimestre precedente) | 5 (-2 vs trimestre precedente) | 6 (-3 vs trimestre precedente) | 12 (+1 vs trimestre precedente) | +240K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $4.205.028 | 282.596 | 27,14% | Azioni |
| Flagship Pioneering, LLC | $3.334.654 | 422.643 | 21,52% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.270.553 | 287.776 | 14,65% | Azioni |
| Vontobel Holding Ltd. | $970.273 | 122.975 | 6,26% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $512.920 | 64.970 | 3,31% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $503.382 | 63.800 | 3,25% | Opzione Put |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $460.208 | 58.328 | 2,97% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $384.125 | 48.685 | 2,48% | Azioni |
| CITADEL ADVISORS LLC | $343.215 | 43.500 | 2,21% | Opzione Put |
| HAP Trading, LLC | $334.750 | 125.000 | 2,16% | Opzione Call |
| STATE STREET CORP | $267.479 | 33.901 | 1,73% | Azioni |
| Lion Point Capital, LP | $249.087 | 31.570 | 1,61% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $244.977 | 31.049 | 1,58% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $223.390 | 28.313 | 1,44% | Azioni |
| MARSHALL WACE, LLP | $217.606 | 27.580 | 1,40% | Azioni |
| XTX Topco Ltd | $163.575 | 20.732 | 1,06% | Azioni |
| GOLDMAN SACHS GROUP INC | $120.157 | 15.229 | 0,78% | Azioni |
| NORTHERN TRUST CORP | $116.409 | 14.754 | 0,75% | Azioni |
| Invesco Ltd. | $102.365 | 12.974 | 0,66% | Azioni |
| MORGAN STANLEY | $93.978 | 11.911 | 0,61% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $87.579 | 11.100 | 0,57% | Opzione Call |
| CITADEL ADVISORS LLC | $82.877 | 10.504 | 0,53% | Azioni |
| SIMPLEX TRADING, LLC | $36.278 | 4.598 | 0,23% | Azioni |
| SBI Securities Co., Ltd. | $32.996 | 4.182 | 0,21% | Azioni |
| Integrated Wealth Concepts LLC | $31.560 | 4.000 | 0,20% | Azioni |
| GROUP ONE TRADING LLC | $29.303 | 3.714 | 0,19% | Azioni |
| JPMORGAN CHASE & CO | $25.832 | 3.316 | 0,17% | Azioni |
| Vanguard Global Advisers, LLC | $15.583 | 1.975 | 0,10% | Azioni |
| BlackRock, Inc. | $13.397 | 1.698 | 0,09% | Azioni |
| Rachor Investment Advisory Services, LLC | $11.654 | 1.477 | 0,08% | Azioni |
| UBS Group AG | $2.627 | 333 | 0,02% | Azioni |
| Tower Research Capital LLC (TRC) | $2.493 | 316 | 0,02% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $1.665 | 211 | 0,01% | Azioni |
| BARCLAYS PLC | $1.318 | 167 | 0,01% | Azioni |
| FMR LLC | $773 | 98 | 0,00% | Azioni |
| Continuum Advisory, LLC | $371 | 47 | 0,00% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $292 | 37 | 0,00% | Azioni |
| Sandy Spring Bank | $242 | 345 | 0,00% | Azioni |
| WELLS FARGO & COMPANY/MN | $79 | 10 | 0,00% | Azioni |
| OSAIC HOLDINGS, INC. | $63 | 8 | 0,00% | Azioni |
| Larson Financial Group LLC | $39 | 5 | 0,00% | Azioni |
| WHITTIER TRUST CO OF NEVADA INC | $8 | 1 | 0,00% | Azioni |
| ROYAL BANK OF CANADA | $0 | 11 | 0,00% | Azioni |
Insider aziendali 32 insider · 16 dirigenti · 17 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Richard N Kender | Interim Chief Executive Officer | 08 Luglio 2026 A | 63.492 | 0 | 0 | $0 |
| Marella Thorell | EVP and Chief Financial Officer | 08 Luglio 2026 A | — | 0 | 0 | $0 |
| David Arkowitz | Chief Financial Officer | 15 Febbraio 2024 M | 182.442 | 0 | 0 | $0 |
| Matthew R. Henn | President and Chief Scientific Officer | 15 Agosto 2026 M | 7.995 | 0 | 5 | $-24.664 |
| Kelly Brady | EVP, Chief Operating Officer | 15 Agosto 2026 M | 8.679 | 0 | 2 | $-735 |
| Thomas Desrosier | EVP and Chief Legal Officer | 15 Agosto 2026 M | 8.117 | 0 | 5 | $-4.209 |
| Teresa L. Young | EVP, Chief Commercial & Strategy Officer | 15 Febbraio 2026 M | 8.557 | 0 | 3 | $-19.644 |
| Lisa Von Moltke | Executive Vice President and Chief Medical Officer | 15 Febbraio 2025 M | 39.875 | 0 | 0 | $0 |
| David S. Ege | Executive Vice President and Chief Technology Officer | 15 Agosto 2024 M | 77.575 | 0 | 0 | $0 |
| Paula Cloghessy | Executive Vice President, Chief People Officer | 27 Ottobre 2023 M | 45.684 | 0 | 0 | $0 |
| Marcus Chapman | SVP, Principal Financial and Accounting Officer | 04 Febbraio 2021 A | 8.600 | 0 | 0 | $0 |
| John G. Aunins | Chief Technology Officer & EVP | 29 Gennaio 2020 A | 105.250 | 0 | 0 | $0 |
| David N Cook | Chief Scientific Officer and EVP of R&D | 26 Gennaio 2019 M | 147.435 | 0 | 0 | $0 |
| Kevin Horgan | Chief Medical Officer and EVP | 25 Gennaio 2019 A | — | 0 | 0 | $0 |
| Michele Trucksis | Chief Medical Officer and EVP | 30 Gennaio 2018 A | 4.893 | 0 | 0 | $0 |
| Wael Hashad | EVP & Chief Commercial Officer | 26 Gennaio 2017 A | — | 0 | 0 | $0 |
| Eric D. Shaff | Direttore | 15 Agosto 2026 M | 12.499 | 0 | 5 | $-12.708 |
| Stephen Berenson | Direttore | 08 Luglio 2026 A | 3.589 | 0 | 0 | $0 |
| Robert L. Rosiello | Direttore | 08 Luglio 2026 A | — | 0 | 0 | $0 |
| Kurt Graves | Direttore | 08 Luglio 2026 A | — | 0 | 0 | $0 |
| Claire Fraser | Direttore | 08 Luglio 2026 A | — | 0 | 0 | $0 |
| Dennis A Ausiello | Direttore | 08 Luglio 2026 A | — | 0 | 0 | $0 |
| Willard H Dere | Direttore | 08 Luglio 2026 A | 31.746 | 0 | 0 | $0 |
| Paul Biondi | Direttore | 10 Aprile 2025 A | 47.619 | 0 | 0 | $0 |
| Hans-Juergen Woerle | Direttore | 04 Febbraio 2025 A | — | 0 | 0 | $0 |
| Gregory Behar | Direttore | 22 Giugno 2023 A | — | 0 | 0 | $0 |
| Meryl Zausner | Direttore | 05 Luglio 2022 A | 31.746 | 0 | 0 | $0 |
| AFEYAN NOUBAR | Direttore | 18 Giugno 2019 P | 4.444.444 | 0 | 0 | $0 |
| Lorence H. Kim | Direttore | 13 Giugno 2019 A | — | 0 | 0 | $0 |
| Roger Pomerantz | Direttore | 13 Giugno 2019 A | 213.976 | 0 | 0 | $0 |
| Peter Barton Hutt | Direttore | 15 Giugno 2016 A | — | 0 | 0 | $0 |
| Werner Cautreels | Direttore | 25 Giugno 2015 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Nestlé S.A., Société des Produits Nestlé S.A. | 02 Ottobre 2024 | — | Deposito iniziale | — | SEC |
| Nestle Health Science US Holdings, Inc., NIMCO US, Inc., Nestlé S.A., Nestlé US Holdco, Inc., Société des Produits Nestlé S.A. ×2 depositi | 22 Luglio 2022 | — | Deposito iniziale | — | SEC |
| Flagship VentureLabs IV, LLC (2), Flagship Ventures Fund IV, L.P. (2), Flagship Ventures Fund IV-Rx, L.P. (2), Flagship Ventures Fund IV General Partner LLC (2), Nutritional Health LTP Fund, L.P. (2), Nutritional Health LTP Fund General Partner LLC (2), Flagship Pioneering Fund VI, L.P. (2), Flagship Pioneering Fund VI General Partner LLC (2), Flagship Pioneering Fund VII, L.P. (2), Flagship Pioneering Fund VII General Partner LLC (2), Flagship Pioneering, Inc. (2), Noubar B. Afeyan, Ph.D. (2) ×3 depositi | 07 Luglio 2022 | — | Deposito iniziale | — | SEC |
| Nestle Health Science US Holdings, Inc. (1), NIMCO US, Inc. (1), Nestlé S.A., Nestlé US Holdco, Inc. (1), Société des Produits Nestlé S.A. | 19 Agosto 2020 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 8 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 25.389 SH | 08 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 12.905 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 5.277 NS | 31 Maggio 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,00% | 37.364 NS | 31 Maggio 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 31.077 NS | 31 Maggio 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 1.022 NS | 31 Maggio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 75.849 SH | 08 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 206.170 SH | 08 Agosto 2026 | Giornaliero |